参考文献/References:
[1].Wrisinger WC,Thompson SL. Basics of extracorporeal membrane oxygenation[J].Surg Clin North Am,2022,102(1):23-35.
[2].Sniderman J,MacLaren G. Pulmonary hypertension and extracorporeal membrane oxygenation—Disparate causes,worse outcomes[J].?Pediatr Crit Care Med,2020,21(3):294-295.
[3].Brodie D,Slutsky AS,Combes A. Extracorporeal life support for adults with respiratory failure and related indications:a review[J].?JAMA,2019,322(6):557-568.
[4].Barbaro RP,MacLaren G,Boonstra PS,et al. Extracorporeal membrane oxygenation support in COVID-19:an international cohort study of the Extracorporeal Life Support Organization registry published correction appears in Lancet[J]. Lancet,2020,396(10257):1071-1078.
[5].Barbaro RP,MacLaren G,Boonstra PS,et al. Extracorporeal membrane oxygenation for COVID-19:evolving outcomes from the international Extracorporeal Life Support Organization Registry[J].?Lancet,2021,398(10307):1230-1238.
[6].Kapur NK. Innovating to resolve the pressure-oxygenation-paradox created by VA-ECMO could improve outcomes for acute myocardial infarction and cardiogenic shock[J]. J Heart Lung Transplant,2024,43(5):700-702.
[7].Guglin M,Zucker MJ,Bazan VM,et al. Venoarterial ECMO for adults:JACC Scientific Expert Panel[J].?J Am Coll Cardiol,2019,73(6):698-716.
[8].Rao P,Khalpey Z,Smith R,et al. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest[J].?Circ Heart Fail,2018,11(9):e004905.
[9].Kiziltug H,Falter F. Circulatory support during lung transplantation[J].?Curr Opin Anaesthesiol,2020,33(1):37-42.
[10].Singh V,Singh G,Arya RC,et al. Vascular access complications in patients undergoing veno-arterial ecmo and their impact on survival in patients with refractory cardiogenic shock:A retrospective 8-year study[J]. Ann Card Anaesth,2022,25(2),171-177.
[11].Gao X,Ninan J,Bohman JK,et al. Extracorporeal membrane oxygenation and acute kidney injury:a single-center retrospective cohort[J].?Sci Rep,2023,13(1):15112.
[12].Rajagopal K,Cheema FH,Omer S. Commentary:Brain damage during extracorporeal membrane oxygenation support:Looking where the light is![J]. J Thorac Cardiovasc Surg,2023,165(6):2112-2113.
[13].Johnson S,Sommer N,Cox-Flaherty K,et al. Pulmonary hypertension: a contemporary review[J].?Am J Respir Crit Care Med,2023,208(5):528-548.
[14].Kelava M,Koprivanac M,Smedira N,et al. Extracorporeal membrane oxygenation in pulmonary endarterectomy patients[J].?J Cardiothorac Vasc Anesth,2019,33(1):60-69.
[15].Sugiyama K,Suzuki S,Fujiyoshi T,et al. Extracorporeal membrane oxygenation after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension[J].?J Card Surg,2019,34(6):428-434.
[16].Delcroix M,de Perrot M,Ja?s X,et al. Chronic thromboembolic pulmonary hypertension: realising the potential of multimodal management[J]. Lancet Respir Med,2023,11(9):836-850.
[17].Mullin CJ,Klinger JR. Chronic thromboembolic pulmonary hypertension[J].?Heart Fail Clin,2018,14(3):339-351.
[18].Otani N,Watanabe R,Tomoe T,et al. Pathophysiology and treatment of chronic thromboembolic pulmonary hypertension[J].?Int J Mol Sci,2023,24(4):3979.
[19].Long F,Luo M,Qin Z,et al. Secondary left heart failure occurred during VA-ECMO assistance for severe residual pulmonary hypertension after pulmonary endarterectomy:a case report[J].?BMC Anesthesiol,2021,21(1):317.
[20].Vaidy A,Vaidya A. Pulmonary arterial hypertension in pregnancy[J].?Curr Opin Cardiol,2023,38(3):250-256.
[21].Vitulo P,Beretta M,Martucci G,et al. Challenge of pregnancy in patients with pre-capillary pulmonary hypertension:veno-arterial extracorporeal membrane oxygenation as an innovative support for delivery[J].?J Cardiothorac Vasc Anesth,2017,31(6):2152-2155.
[22].Sankaran D,Lakshminrusimha S. Pulmonary hypertension in the newborn—Etiology and pathogenesis[J].?Semin Fetal Neonatal Med,2022,27(4):101381.
[23].Song S,Park KH,Lee H,et al. Veno-arterial extracorporeal membrane oxygenation for the treatment of persistent pulmonary hypertension in the newborn[J].?Asian J Surg,2023,46(2):1145-1146.
[24].Hu H,Jing X,Duan X,et al. Congenital diaphragmatic hernia[J].?Pediatr Pulmonol,2023,58(9):2666-2667.
[25].Stewart LA,Klein-Cloud R,Gerall C,et al. Extracorporeal membrane oxygenation (ECMO) and its complications in newborns with congenital diaphragmatic hernia[J].?J Pediatr Surg,2022,57(8):1642-1648.
[26].O’Connor E,Tamura R,Hannon T,et al. Congenital diaphragmatic hernia survival in an English regional ECMO center[J]. World J Pediatr Surg,2023,6(2):e000506.
[27].Messika J,Eloy P,Boulate D,et al. Protocol for venoarterial ExtraCorporeal Membrane Oxygenation to reduce morbidity and mortality following bilateral lung TransPlantation:the ECMOToP randomised controlled trial[J]. BMJ Open,2024,14(3):e077770.
[28].St?cel T,Kegler K,M?drala A,et al. Lung transplantation in patients with pulmonary hypertension with extracorporeal membrane oxygenation (ECMO) support:5-year experience[J]. Transplant Proc,2024,56(4):898-903.
[29].St?cel T,Antończyk R,Latos M,et al. Extracorporeal membrane oxygenation as a postoperative left ventricle conditioning tool after lung transplantation in patients with primary pulmonary artery hypertension:first Polish experience[J].?Transplant Proc,2020,52(7):2113-2117.
[30].Blakeslee-Carter J,Shao C,LaGrone R,et al. Vascular complications based on mode of extracorporeal membrane oxygenation[J]. J Vasc Surg,2022,75(6):2037-2046.
[31].Nunez JI,Gosling AF,O’Gara B,et al. Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation:an ELSO registry analysis[J].?Intensive Care Med,2022,48(2):213-224.
[32].Bartlett R,Arachichilage DJ,Chitlur M,et al. The history of extracorporeal membrane oxygenation and the development of extracorporeal membrane oxygenation anticoagulation[J]. Semin Thromb Hemost,2024,50(1):81-90.
[33].Biffi S,Di Bella S,Scaravilli V,et al. Infections during extracorporeal membrane oxygenation:epidemiology,risk factors,pathogenesis and prevention[J].?Int J Antimicrob Agents,2017,50(1):9-16.
[34].Pe?a-López Y,Machado MC,Rello J. Infection in ECMO patients:changes in epidemiology,diagnosis and prevention[J]. Anaesth Crit Care Pain Med,2024,43(1):101319.
[35].Minc SD,Hayanga HK,Thibault D,et al. Vascular complications increase hospital charges and mortality in adult patients on extracorporeal membrane oxygenation in the United States [J].?Semin Thorac Cardiovasc Surg,2021,33(2):397-406.
[36].Shigemura N,Kehara H,Toyoda Y. Peripheral veno-arterial extracorporeal membrane oxygenation during lung transplantation with special reference to differential hypoxemia and vascular complications[J]. J Thorac Dis,2024,16(1):798-803.
[37].Chen YC,Tsai FC,Fang JT,et al. Acute kidney injury in adults receiving extracorporeal membrane oxygenation[J].?J Formos Med Assoc,2014,113(11):778-785.
[38].Guru PK,Balasubramanian P,Ghimire M,et al. Acute kidney injury in patients before and after extracorporeal membrane oxygenation (ECMO)—Retrospective longitudinal analysis of the hospital outcomes[J]. J Crit Care,2024,81:154528.
[39].Chapman JT,Breeding J,Kerr SJ,et al. CNS complications in adult patients treated with extracorporeal membrane oxygenation[J].?Crit Care Med,2021,49(2):282-291.
[40].Cho SM,Canner J,Chiarini G,et al. Modifiable risk factors and mortality from ischemic and hemorrhagic strokes in patients receiving venoarterial extracorporeal membrane oxygenation:results from the Extracorporeal Life Support Organization Registry[J].?Crit Care Med,2020,48(10):e897-e905.
相似文献/References:
[1]孟晓冬,单福祥,综述,等.肺动脉高压治疗进展[J].心血管病学进展,2016,(3):319.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.028]
MENG Xiaodong,SHAN Fuxiang,WANG Yanhui.Advances in Research of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2016,(11):319.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.028]
[2]张艺韬,综述,曾伟杰,等.左心疾病相关肺动脉高压流行病学[J].心血管病学进展,2016,(4):333.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.002]
ZHANG Yitao,ZENG Weijie,CHENG Kanglin.Epidemiology of Pulmonary Hypertension due to Left Heart Disease[J].Advances in Cardiovascular Diseases,2016,(11):333.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.002]
[3]汪汉,刘英杰,王燕凤.长链非编码RNA与肺动脉高压[J].心血管病学进展,2019,(6):898.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.015]
WANG Han,LIU Yingjie,WANG Yanfeng.Long Non-coding RNA in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2019,(11):898.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.015]
[4]汪汉 邓祁 刘英杰.系统性红斑狼疮相关肺动脉高压的诊断、治疗及预后[J].心血管病学进展,2019,(8):1142.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.018]
WANG Han,DENG Qi,LIU Yingjie.Diagnosis,Treatment and Prognosis of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus[J].Advances in Cardiovascular Diseases,2019,(11):1142.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.018]
[5]段宇 贾静 步睿 李涛 韦宏.急性伊洛前列素吸入对肺动脉高压患者右心室功能的影响[J].心血管病学进展,2019,(9):1319.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.034]
DUAN Yu,JIA Jing,BU Rui,et al.The Effect of Acute Iloprost Inhalation on Right Ventricular Function in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2019,(11):1319.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.034]
[6]查玉杰 何庆.肺动脉高压发生发展中的相关因子[J].心血管病学进展,2020,(2):192.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.024]
ZHA YujieHE Qing.The Relevant Factors in the Development of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2020,(11):192.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.024]
[7]朱珊英,朱国斌.肺动脉高压发病机制新进展[J].心血管病学进展,2020,(3):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
ZHU Shanying,ZHU Guobin.Pathogenesis of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2020,(11):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
[8]韩柯,孟祥光,赵育洁.趋化因子及其受体在肺动脉高压中的研究进展[J].心血管病学进展,2020,(3):296.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.020]
HAN Ke,MENG Xiangguang,ZHAO Yujie.Chemokines and Their Receptors in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2020,(11):296.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.020]
[9]刘超 曲杰 王明娟 徐倩 范彦芳 周晓慧 单伟超.肺动脉高压对扩张型心肌病预后的影响[J].心血管病学进展,2020,(4):424.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.023]
LIU ChaoQU JieWANG MingjuanXU QianFAN YanfangZHOU XiaohuiSAN Weichao.The Effect of Pulmonary Hypertension on the Prognosis of Dilated Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(11):424.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.023]
[10]向杰 刘明鑫 张伟 黄从新.基于生物信息学分析探究肺动脉高压关键基因和通路[J].心血管病学进展,2020,(4):428.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.024]
Xiang JieLiu MingxinZhang WeiHuang Congxin.Bioinformatics Analysis of Key Genes and Pathways in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2020,(11):428.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.024]